ENDS Cardiovascular System: Difference between revisions

Added icon
No edit summary
 
(One intermediate revision by one other user not shown)
Line 67: Line 67:
(Jacob George, MD, Muhammad Hussain, MSc, Thenmalar Vadiveloo, PhD, Sheila Ireland, BSc, Pippa Hopkinson, BSc, Allan D.Struthers, MD, Peter T. Donnan, PhD, Faisel Khan, PhD, Chim C.Lang, MD
(Jacob George, MD, Muhammad Hussain, MSc, Thenmalar Vadiveloo, PhD, Sheila Ireland, BSc, Pippa Hopkinson, BSc, Allan D.Struthers, MD, Peter T. Donnan, PhD, Faisel Khan, PhD, Chim C.Lang, MD
E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD.
E-cigarette (EC) use is increasing exponentially worldwide. The early cardiovascular effects of switching from tobacco cigarettes (TC) to EC in chronic smokers is unknown. Meta-analysis of flow-mediated dilation (FMD) studies indicate 13% lower pooled, adjusted relative risks of cardiovascular events with every 1% improvement in FMD.
*See additional comments: [https://www.sciencemediacentre.org/expert-reaction-to-the-vesuvius-study-comparing-the-cardiovascular-effects-of-smoking-and-vaping/ Science Media Centre]
 
 


===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592370/ 2019: Electronic cigarettes and cardiovascular health: what do we know so far?]=== <!--T:15-->
===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592370/ 2019: Electronic cigarettes and cardiovascular health: what do we know so far?]=== <!--T:15-->
Line 164: Line 162:




===2017: Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents=== <!--T:35-->
===2017: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634299/#:~:text=In%20conclusion%2C%20the%20acute%20sympathomimetic,constituents%20in%20e%E2%80%90cigarette%20aerosol. Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents]=== <!--T:35-->


<!--T:36-->
<!--T:36-->
Line 173: Line 171:




===2016: Cardiovascular toxicity of nicotine: Implications for electronic cigarette use=== <!--T:37-->
===2016: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958544/#:~:text=Catecholamine%20release%20from%20nicotine%20could,fibrillation%20after%20experimental%20myocardial%20infarction. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use]=== <!--T:37-->


<!--T:38-->
<!--T:38-->